Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. (Q34609020)

From Wikidata

Jump to navigation Jump to search

scientific article

Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference ‘research perspectives in AF’

Language	Label	Description	Also known as
English	Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.	scientific article	Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference ‘research perspectives in AF’

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. (English)

1 reference

Europe PubMed Central

3 August 2017

atrial fibrillation

0 references

object named as

Stanley Nattel

14

0 references

Paulus Kirchhof

object named as

Paulus Kirchhof

1

0 references

13

object named as

Gregory Y H Lip

1 reference

Europe PubMed Central

3 August 2017

Karl-Heinz Kuck

12

object named as

Karl-Heinz Kuck

1 reference

Europe PubMed Central

3 August 2017

4

object named as

Hugh Calkins

1 reference

Europe PubMed Central

3 August 2017

Jeroen Joost Bax

2

object named as

Jeroen Bax

1 reference

Europe PubMed Central

3 August 2017

Günter Breithardt

23

object named as

Günter Breithardt

1 reference

Europe PubMed Central

3 August 2017

10

object named as

Andreas Goette

1 reference

Europe PubMed Central

3 August 2017

Ulrich Schotten

17

object named as

Ulrich Schotten

1 reference

Europe PubMed Central

3 August 2017

Harry J. G. M. Crijns

8

object named as

Harry Crijns

1 reference

Europe PubMed Central

3 August 2017

5

object named as

A John Camm

1 reference

Europe PubMed Central

3 August 2017

19

object named as

Panos Vardas

1 reference

Europe PubMed Central

3 August 2017

Carsten W. Israel

11

object named as

Carsten W Israel

1 reference

Europe PubMed Central

3 August 2017

Carina Blomstrom-Lundquist

3

object named as

Carina Blomstrom-Lundquist

1 reference

Europe PubMed Central

3 August 2017

Riccardo Cappato

6

object named as

Ricardo Cappato

1 reference

Europe PubMed Central

3 August 2017

Hans-Christian Diener

9

object named as

Hans-Christian Diener

1 reference

Europe PubMed Central

3 August 2017

Gerhard Steinbeck

18

object named as

Gerhard Steinbeck

1 reference

Europe PubMed Central

3 August 2017

Karl Wegscheider

21

object named as

Karl Wegscheider

1 reference

Europe PubMed Central

3 August 2017

author name string

Francisco Cosio

7

1 reference

Europe PubMed Central

3 August 2017

Richard L Page

15

1 reference

Europe PubMed Central

3 August 2017

Ursula Ravens

16

1 reference

Europe PubMed Central

3 August 2017

Albert Waldo

20

1 reference

Europe PubMed Central

3 August 2017

Stephan Willems

22

1 reference

Europe PubMed Central

3 August 2017

publication date

1 December 2009

1 reference

Europe PubMed Central

3 August 2017

European Heart Journal

1 reference

Europe PubMed Central

3 August 2017

30

1 reference

Europe PubMed Central

3 August 2017

24

1 reference

Europe PubMed Central

3 August 2017

2969-77c

1 reference

Europe PubMed Central

3 August 2017

Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

The Tel Aviv Stroke Registry. 3600 consecutive patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Atrial fibrillation and stroke. Mortality and causes of death after the first acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Stroke severity in atrial fibrillation. The Framingham Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Quality of life in patients with atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

A comparison of rate control and rhythm control in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Rhythm control versus rate control for atrial fibrillation and heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Effect of dronedarone on cardiovascular events in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

New ideas about atrial fibrillation 50 years on.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Repolarization and activation restitution near human pulmonary veins and atrial fibrillation initiation: a mechanism for the initiation of atrial fibrillation by premature beats

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Rapid and stable re-entry within the pulmonary vein as a mechanism initiating paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Mechanism of origin of conduction disturbances in aging human atrial bundles: experimental and model study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Heart-directed expression of a human cardiac isoform of cAMP-response element modulator in transgenic mice

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Outcome parameters for trials in atrial fibrillation: executive summary

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

New concepts for old drugs to maintain sinus rhythm in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Catheter ablation for atrial fibrillation in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

The ligament of Marshall: a structural analysis in human hearts with implications for atrial arrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Radiofrequency catheter ablation of atrial fibrillation initiated by spontaneous ectopic beats

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Critical atrial site for ablation of pacing-induced atrial fibrillation in the normal dog heart.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Successful surgical treatment of atrial fibrillation. Review and clinical update

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Pulmonary vein region ablation in experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic ganglia

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Valsartan for prevention of recurrent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

The Canadian Registry of Atrial Fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Challenges of establishing new antithrombotic therapies in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Genetic determinants of response to warfarin during initial anticoagulation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Systematic overview of warfarin and its drug and food interactions

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Consensus document on antithrombotic therapy in the setting of electrophysiological procedures

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committ

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Clinical outcome of mitral regurgitation due to flail leaflet

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Influence of etiology of atrial fibrillation on incidence of systemic embolism

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Surgical treatment of chronic atrial fibrillation combined with rheumatic mitral valve disease: Effects of the cryo-maze procedure and predictors for late recurrence.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Scaling up interventions for chronic disease prevention: the evidence

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Natural history of decline in instrumental activities of daily living performance over the 10 years preceding the clinical diagnosis of dementia: a prospective population-based study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Subtle neurological abnormalities as risk factors for cognitive and functional decline, cerebrovascular events, and mortality in older community-dwelling adults.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Twist and untwist mechanics of the left ventricle

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Silent brain infarcts and the risk of dementia and cognitive decline.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implications.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Incidence and Predictors of Very Late Recurrence of Atrial Fibrillation After Ablation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP235

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHP235

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34609020&oldid=2074825285"